Thermo Fisher Scientific (TMO) Operating Expenses (2009 - 2026)

Thermo Fisher Scientific has reported Operating Expenses for 18 years, with the latest figure at $9.9 billion in Q2 2026.

• Operating Expenses for Q2 2026 came in at $9.9 billion, up 9.82% year-over-year; the trailing twelve-month figure through Jun 2026 was $38.2 billion (up 6.66% YoY), and the FY2025 annual result was $36.8 billion, up 3.57% from the prior year.
• Operating Expenses rose to $9.9 billion in Q2 2026, from $9.1 billion in the prior quarter.
• Over five years, Operating Expenses peaked at $10.0 billion in Q4 2025 and troughed at $8.6 billion in Q1 2025.
• A 5-year average of $9.1 billion and a median of $9.0 billion in 2023 frame the typical range for Operating Expenses.
• The widest annual swing landed in 2022, when Operating Expenses soared 31.21%; it then retreated 5.81% in 2023.
• A 5-year view of Operating Expenses shows it stood at $9.6 billion in 2022, then decreased by 5.81% to $9.0 billion in 2023, then grew by 3.84% to $9.4 billion in 2024, then increased by 6.19% to $10.0 billion in 2025, then dropped by 0.53% to $9.9 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $9.9 billion in Q2 2026, $9.1 billion in Q1 2026, and $10.0 billion in Q4 2025.